Evidence map›Paper›PMID 26063704›Full record

ArticleAmerican journal of physiology. Cell physiology2015

β3-Adrenoceptor activation relieves oxidative inhibition of the cardiac Na+-K+ pump in hyperglycemia induced by insulin receptor blockade.

Keyvan Karimi Galougahi, Chia-Chi Liu, Alvaro Garcia, Natasha A Fry, Elisha J Hamilton, Gemma A Figtree, Helge H Rasmussen

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. βJournal of cellular physiology · 2019
    Article
  7. Cardiac βBritish journal of pharmacology · 2019
    Review
  8. Role of the βMolecular and cellular biochemistry · 2018
    Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Keyvan Karimi GalougahiNorth Shore Heart Research Group, Kolling Institute, University of Sydney, Sydney, Australia; and Department of Cardiology, Royal North Shore Hospital, Sydney, Australia.
Chia-Chi LiuNorth Shore Heart Research Group, Kolling Institute, University of Sydney, Sydney, Australia; and.
Alvaro GarciaNorth Shore Heart Research Group, Kolling Institute, University of Sydney, Sydney, Australia; and.
Natasha A FryNorth Shore Heart Research Group, Kolling Institute, University of Sydney, Sydney, Australia; and.
Elisha J HamiltonNorth Shore Heart Research Group, Kolling Institute, University of Sydney, Sydney, Australia; and.
Gemma A FigtreeNorth Shore Heart Research Group, Kolling Institute, University of Sydney, Sydney, Australia; and Department of Cardiology, Royal North Shore Hospital, Sydney, Australia.
Helge H RasmussenNorth Shore Heart Research Group, Kolling Institute, University of Sydney, Sydney, Australia; and Department of Cardiology, Royal North Shore Hospital, Sydney, Australia helge.rasmussen@sydney.edu.au.
University of Sydney · AURoyal North Shore Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysregulated nitric oxide (NO)- and superoxide (O2 (·-))-dependent signaling contributes to the pathobiology of diabetes-induced cardiovascular complications. We examined if stimulation of β3-adrenergic receptors (β3-ARs), coupled to endothelial NO synthase (eNOS) activation, relieves oxidative inhibition of eNOS and the Na(+)-K(+) pump induced by hyperglycemia. Hyperglycemia was established in male New Zealand White rabbits by infusion of the insulin receptor antagonist S961 for 7 days. Hyperglycemia increased tissue and blood indexes of oxidative stress. It induced glutathionylation of the Na(+)-K(+) pump β1-subunit in cardiac myocytes, an oxidative modification causing pump inhibition, and reduced the electrogenic pump current in voltage-clamped myocytes. Hyperglycemia also increased glutathionylation of eNOS, which causes its uncoupling, and increased coimmunoprecipitation of cytosolic p47(phox) and membranous p22(phox) NADPH oxidase subunits, consistent with NADPH oxidase activation. Blocking translocation of p47(phox) to p22(phox) with the gp91ds-tat peptide in cardiac myocytes ex vivo abolished the hyperglycemia-induced increase in glutathionylation of the Na(+)-K(+) pump β1-subunit and decrease in pump current. In vivo treatment with the β3-AR agonist CL316243 for 3 days eliminated the increase in indexes of oxidative stress, decreased coimmunoprecipitation of p22(phox) with p47(phox), abolished the hyperglycemia-induced increase in glutathionylation of eNOS and the Na(+)-K(+) pump β1-subunit, and abolished the decrease in pump current. CL316243 also increased coimmunoprecipitation of glutaredoxin-1 with the Na(+)-K(+) pump β1-subunit, which may reflect facilitation of deglutathionylation. In vivo β3-AR activation relieves oxidative inhibition of key cardiac myocyte proteins in hyperglycemia and may be effective in targeting the deleterious cardiac effects of diabetes.

Indexed as

Adrenergic beta-3 Receptor AgonistsAmino Acid SequenceAnimalsBlood GlucoseDioxolesHyperglycemiaMaleMolecular Sequence DataOxidative StressRabbitsReceptor, InsulinReceptors, Adrenergic, beta-3Sodium-Potassium-Exchanging ATPaseAdrenergic beta-3 Receptor AgonistsBlood GlucoseDioxolesdisodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylateReceptor, InsulinReceptors, Adrenergic, beta-3Sodium-Potassium-Exchanging ATPasediabetesendothelial nitric oxide synthaseglutathionylationhyperglycemiaNa+-K+ pumpβ3-adrenergic receptors

Identifiers

PMID26063704
PMCPMC4556897
OpenAlexW1916647147

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.